At present, the drugs targeting pancreatic cancer stem cells mainly include Reactive oxygen species (ROS) inhibitors, acetylsalicylic acid, mTOR inhibitors, metformin, etc (48). Here, MTOR is linked to familial pancreatic carcinoma.